Home > News > Headline News > Archive

Click on title to read the full article.

Metastatic Cancer in Solid Tumors and Clinical Outcome: Skeletal-Related Events

December 30, 2011

By CancerNetwork

Metastasis to the bone represents a frequent complication of visceral cancers, most commonly in patients with advanced breast, prostate, and lung cancer.

Fulvestrant Adds Punch to Anastrozole for HR+ Breast Cancer

December 30, 2011

By The Oncology Report

Combination therapy with anastrozole and fulvestrant might be a new first-line treatment option for postmenopausal women with hormone receptor–positive breast cancer.

Pertuzumab enhances outcomes in HER2-positive breast cancer

December 29, 2011

By Oncology Nurse Advisor

Women with HER2-positive breast cancer had an improved rate of complete tumor disappearance in just 12 weeks when the monoclonal antibody pertuzumab was added to the standard therapy, consisting of trastuzumab plus the chemotherapy agent docetaxel.

Amgen Plans to Team Up With Watson on Generics

December 23, 2011

By Andrew Pollack, NYT

Amgen, the biotechnology company, is planning to develop generic versions of some best-selling drugs.

Randomized Trial of Yoga in Metastatic Breast Cancer Affects Mood and Biology

December 17, 2011

By Nick Mulcahy

The practice of yoga might reduce psychological distress and modulate abnormal cortisol levels and immune responses in patients with metastatic breast cancer, according to a study presented here at the 34th Annual San Antonio Breast Cancer Symposium.

Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television

December 17, 2011

By Generex Biotechnology Corporation

Generex Biotechnology Corporation (OTCBB: GNBT.OB) today announced that Bloomberg Television will air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc.

Novel Hormone Therapy Combination Shown to Prolong Survival

December 17, 2011

By Elizabeth Whittington

A phase 3 randomized trial of two hormone therapies, anastrozole and Faslodex (fulvestrant), showed that in some postmenopausal women with hormone-positive metastatic breast cancer, the combo improves survival.

SABCS: Surgery May Help in Advanced Breast Cancer

December 17, 2011

By Vandana Abramson, MD

Surgical removal of primary breast cancer tumors of women who present with metastatic disease might improve local disease control and possibly overall survival, researchers suggested here.

SABCS: Liposomal Doxorubicin Safe in Advanced Breast Ca

December 16, 2011

By Vandana Abramson, MD

Women with advanced breast cancer who have been pretreated with anthracyclines can be safely treated with nonpegylated liposomal doxorubicin (Myocet) along with docetaxel (Taxotere) with little effect on cardiac risk, researchers reported here.

SABCS: Addition of Everolimus Helps Slow Breast Cancer

December 15, 2011

By Robert Jasmer

The combination of everolimus (Afinitor) and the aromatase inhibitor exemestane (Aromasin) extended progression-free survival in women diagnosed with metastatic breast cancer by more than four months, researchers said here.

 1 2 3 >